| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 04/05/2007 | WO2006073419A3 Lipoprotein nanoplatforms |
| 04/05/2007 | US20070078099 Method of preventing, treating and diagnosing disorders of protein aggregation |
| 04/05/2007 | US20070077199 Humanized collagen antibodies and related methods |
| 04/05/2007 | US20070077198 precursor for preparing 3'-Deoxy-3'-[18F]-fluoro-thymidine (18F-FLT), that has been used for visualizing DNA in Positron emission tomography; produces low amounts of chromophoric byproducts during the deprotection step in preparation process |
| 04/05/2007 | US20070077197 Cancer diagnosis; antitumor agents, radiotherapy |
| 04/05/2007 | US20070077196 Radiolabeled thymidine solid-phase extraction purification method |
| 04/05/2007 | US20070077195 "N and/or nalpha derivatized, metal and organic protected l-histidine for coupling to biomolecules for highly efficient labeling with [m(oh2)3 (co)3]+ by fac coordination" |
| 04/05/2007 | US20070076834 Radium Target and method for producing it |
| 04/05/2007 | CA2623554A1 Methods and therapies for treating inflammatory conditions with exposed collagen |
| 04/05/2007 | CA2623252A1 Benzothiazole cyclobutyl amine derivatives and their use as histamine-3 receptors ligands |
| 04/04/2007 | EP1768709A1 A method of diagnosing prodromal forms of diseases associated with amyloid deposition |
| 04/04/2007 | EP1768708A2 N4 chelator conjugates |
| 04/04/2007 | EP1768706A2 Radiolabeled nanohybrids targeting solid tumor neovasculature and method of using same |
| 04/04/2007 | EP1259595B1 Integrin antagonists |
| 04/04/2007 | CN1308339C 99m Tc marked polyamine complex as tumor diagnosing developing agent and its preparation |
| 04/03/2007 | US7198788 Administering pharmaceutical formulation comprising an anti-CD26 antibody, whereby the anti- CD26 antibody binds CD26 and arrests cell cycle for therapy of cancer |
| 04/03/2007 | US7198775 Detectably labeled porphyrin compound for identifying the sentinel lymph node |
| 04/03/2007 | CA2259950C Radiometal-binding peptide analogues |
| 04/03/2007 | CA2157530C Somatostatin analogs containing chelating groups and their radiolabeled compositions |
| 03/29/2007 | WO2007013894A9 Phospholipid ether analogs for detecting and treating cancer |
| 03/29/2007 | WO2005097211A3 Compositions as adjuvants to improve immune responses to vaccines and methods of use |
| 03/29/2007 | US20070073308 Method and apparatus for EMR treatment |
| 03/29/2007 | US20070073114 Method and apparatus for post-processing of a 3D image data record, in particular for virtual colonography |
| 03/29/2007 | US20070072251 In vivo imaging using peptide derivatives |
| 03/29/2007 | US20070071685 Gas-filled microvesicle assembly for contrast imaging |
| 03/29/2007 | US20070071678 Electrical initiation system |
| 03/29/2007 | US20070071677 Non-toxic membrane-translocating peptides |
| 03/29/2007 | US20070071676 Methods and Therapies for Treating Inflammatory Conditions with Exposed Collagen |
| 03/29/2007 | US20070071675 Engineered multivalent and multispecific binding proteins; treatment of acute and chronic inflammatory, cancer |
| 03/29/2007 | US20070071674 Polynucleotides encoding novel isoforms of IGSF9 |
| 03/29/2007 | US20070071673 Trifunctional reagent for conjugation to a biomolecule |
| 03/29/2007 | US20070071672 Use of metal tricarbonyl complexes as radiotherapeutic chemotoxic agents |
| 03/29/2007 | US20070071671 Process for producing radioactive-fluorine-labeled compound |
| 03/29/2007 | US20070071670 Diagnostic imaging agents with mmp inhibitory activity |
| 03/28/2007 | EP1767224A2 Steroismers of fatty acid analogs for diagnostic imaging |
| 03/28/2007 | EP1765419A1 Stabilized and lyophilized radiopharmaceutical agents for destroying tumors |
| 03/28/2007 | EP1292298B1 Intracorporeal medicaments for high energy phototherapeutic treatment of disease |
| 03/27/2007 | US7196063 Peptides and pharmaceutical compositions comprising same |
| 03/27/2007 | US7195751 For the determination of an analyte or analytes such as proteins, peptides, nucleic acids, carbohydrates, lipids, steroids and small molecules by mass analysis |
| 03/27/2007 | US7195750 Clinical parameters for determining hematologic toxicity prior to radioimmunotherapy |
| 03/27/2007 | CA2431660C Stabilised radiopharmaceutical compositions |
| 03/27/2007 | CA2242750C Antibodies with reduced net positive charge |
| 03/22/2007 | WO2007033090A2 Method for diagnosis of chronic allograft rejection |
| 03/22/2007 | WO2007032005A2 Novel amine-borane compounds and uses thereof |
| 03/22/2007 | WO2007005283A3 Use of dtbz for imaging endocrine pancreas and beta cell mass in type 1 diabetes |
| 03/22/2007 | WO2006114474A3 Saline solution comprising [13n] nh4+ and a device |
| 03/22/2007 | WO2005092377A9 Cytotoxicity mediation of cells evidencing surface expression of cd63 |
| 03/22/2007 | US20070066798 Diagnostic and therapeutic use of antibodies against the urokinase receptor |
| 03/22/2007 | US20070066535 Novel amino acid sequences are within the carboxy termini of fibrinogen; useful for cell culture and cell separation |
| 03/22/2007 | US20070065879 Marker for inflammatory conditions |
| 03/22/2007 | US20070065849 Nucleic acid encoding eosinophil eotaxin receptor |
| 03/22/2007 | US20070065821 Methods for the prediction of suicidality during treatment |
| 03/22/2007 | US20070065362 Gastrin receptor-avid peptide conjugates |
| 03/22/2007 | US20070065361 Targeting ligands for radiation guided delivery of an actice agent that bind to a TIP-1 polypeptide |
| 03/22/2007 | US20070065360 Nonpolar thymidine analogs |
| 03/22/2007 | US20070065359 Nanocells for diagnosis and treatment of diseases and disorders |
| 03/21/2007 | EP1764352A1 A conventional method for the preparation of new precursor of no-carrier-adde O-(2-[18F]fluoroethyl)-L-tyrosine |
| 03/21/2007 | EP1763372A2 Radionuclides for medical use |
| 03/21/2007 | EP1763371A2 Novel imaging agents comprising caspase-3 inhibitors |
| 03/21/2007 | CN1934247A Cancerous disease modifying antibodies |
| 03/21/2007 | CN1934246A Cancerous disease modifying antibodies |
| 03/21/2007 | CN1931878A Platelet aggregation resistant chimeric monoclonal antibody and/or its fragment |
| 03/21/2007 | CN1305871C Novel piperazinyl-pyrazinone derivatives for the treatment of 5-HT2a receptor-related disorders |
| 03/20/2007 | US7192586 Topical administration of an anti-PSMA antibody alone or conjugated to a cytotoxic moiety to the extracellular domain of human prostate specific membrane antigen (PSMA); anti-proliferative agents and - carcinogenic agents |
| 03/20/2007 | US7192570 Compositions of somatostatin analogues |
| 03/20/2007 | US7192556 Flow cell, method for separating carrier-free radionuclides, and the radiochemical reaction thereof |
| 03/20/2007 | CA2211100C Diagnostic imaging contrast agents with extended blood retention |
| 03/20/2007 | CA2180954C Inhibitors of human plasmin derived from the kunitz domains |
| 03/20/2007 | CA2142280C Metal-mediated cross-coupling with ring-metalated porphyrins |
| 03/15/2007 | WO2007030571A2 Identification of targets and development of reagents for testing and molecular imaging of human disease |
| 03/15/2007 | WO2007030012A2 Extracellular matrix imaging |
| 03/15/2007 | WO2007028639A1 Method for the synthesis of pentapendant enantiomer-pure chelators and process for therapeutically active bio-conjugates preparation by a covalent binding of thereof |
| 03/15/2007 | WO2003068169A3 Stabilized synthetic immunogen delivery system |
| 03/15/2007 | US20070060618 Alkyne derivatives as tracers for metabotropic glutamate receptor binding |
| 03/15/2007 | US20070059246 Use of bile acid derivatives conjugated with metal ion chelated complexes for the diagnostic assessment of microvascular permeability |
| 03/15/2007 | US20070059241 neutralizing monoclonal antibodies against human Insulin-like Growth Factor Receptor-I (IGFR1); anticancer agent |
| 03/15/2007 | US20070059240 Via administering radiolabelled antibody to tertiary lymphoid organs in as marker of chronic rejection by immunohistochemical detection for presence of specific TLO antigens in biopsy samples or by radiographic imaging of radiolabeled antibodies |
| 03/15/2007 | US20070059239 Process for the preparation of radioactive labeled estradiol |
| 03/15/2007 | US20070059230 Process |
| 03/14/2007 | EP1761560A1 Peptide-based compounds |
| 03/14/2007 | EP1098979B1 Antibody with improved producibility |
| 03/14/2007 | CN1929869A Phospholipid analogs as diagnostic and therapeutic agents for numerous cancers |
| 03/14/2007 | CN1927913A Chemical preparation method of hollow polymer microsphere with controllable open pores |
| 03/14/2007 | CN1927421A Pipe support capable of load-bearing minisize active particle source |
| 03/14/2007 | CN1927400A Biomagnetism nano target anti-cancer drug and its preparation |
| 03/14/2007 | CN1304400C Diphosphonic acid derivative, radioactive 99mTc labeled diphosphonic acid derivative and uses thereof |
| 03/14/2007 | CN1304058C Water soluble paclitaxel prodrugs |
| 03/13/2007 | US7189825 Monoclonal antibody for use in diagnosis, prevention and treatment of cell proliferative disorders; antitumor agents; immunotherapy |
| 03/13/2007 | US7189536 Which is incapable of reproduction within human cell lines; for treatment of human immunodeficency virus |
| 03/13/2007 | US7189383 Compounds with halogen for diagnosis with ethers or sulfides for cancer |
| 03/13/2007 | CA2222966C Thiolation of peptides for radionuclide-based radiodetection and radiotherapy |
| 03/13/2007 | CA2171111C Inhibition of urinary calculi growth |
| 03/08/2007 | WO2007027385A2 F-18 peptides for pre targeted positron emission tomography imaging |
| 03/08/2007 | WO2007026960A1 Use of mocs3 gene for therapeutic or diagnostic purposes |
| 03/08/2007 | WO2007026216A1 Method for the use of [11c] carbon monoxide in labeling synthesis of 11c-labelled ketones by photo-induced free radical carbonylation |
| 03/08/2007 | WO2007026140A2 Use of a labelled marker for determinating the kidney function |
| 03/08/2007 | WO2006134424A3 Method for the use of [11c] carbon monoxide in labeling synthesis of 11c-labelled acids by photo-induced free radical carbonylation |
| 03/08/2007 | US20070053838 Comprises therapeutically effective amounts of at least one chemotherapeutic agent along with the biotherapeutic endogenous pentapeptide Met-enkephalin (opioid growth factor); cancer |
| 03/08/2007 | US20070053837 Radiopharmaceuticals for cancer diagnosis and treatment |
| 03/08/2007 | US20070053836 Cytotoxicity mediation of cells evidencing surface expression of CD44 |